43 ms·
I wasted $40k on a fantastic startup idea
- forgotmypw17 6y agoJust want to say, if I ever get a headache, I don't try to block it with a pain pill, but do what my body's asking me to, very loudly, which is to sleep and rest.
- rel2thr 6y agoI like your idea, but I’m confused why you didn’t try the webmd competitor route.. 50c/user that webmd makes is pretty good really , with good SEO + content marketing you could scale to enough users to make things interesting
- sixQuarks 6y agoExactly. This was the right path in this case. The value is for the consumer, if he could attract just 100K visitors per month, that's $500,000/year. Not only that, he would have a highly targeted group of users that he could tailor all kinds of products and services to.
- ivalm 6y agoYou need 1mil visitors for 500k.
- saaaaaam 6y agoIndeed. Which what 100k per month comes to, give or take :)
- yaboy 6y agoYou’re both wrong. 100k visitors per month ≠ 100k unique users per month. Very different things!
- sixQuarks 6y agoYou're being super nit-picky. It should have been assumed 100K "visitors" meant uniques, but I knew someone like you might make this comment. 100K * 12 = 1,200,000 visitors. I added a 20% margin to account for return visitors.
- yaboy 6y agoI’d like to see you tell your founder or CMO that the difference between monthly visitors and monthly unique visitors is “super nit-picky”. The 20% margin is risible and those who live by SEO die by SEO: https://cdixon.org/2011/03/05/seo-is-no-longer-a-viable-marketing-strategy-for-startups https://cdixon.org/2011/03/05/seo-is-no-longer-a-viable-mark...
- saaaaaam 6y agoWell, quite! But then I pretty much assumed it was a shorthand amongst peers so (over) explanation perhaps wasn’t really necessary...
- extrememacaroni 6y agoThis reminds me of an idea I had days ago of using an AI to tell poisonous mushrooms from edible ones apart, from photos. Then I realized I don't want to be responsible for anyone's death.
- syntaxing 6y agoWhat if you limited the range from I don’t know if it’s poisonous to X% likely poisonous vs is/is not poisonous?
- eropple 6y agoPeople empirically do not understand probability in a useful way. Folks will, in aggregate, read that as "X% poisonous", not "X% chance to be kill you." "Oh, that's only 25%, it'll be fiiine."
- byecomputer 6y agoEven if you can avoid being liable for it, I'd think most people wouldn't want someone's death hanging over their head for reasons beyond the legal.
- frompdx 6y agoDefinitely a neat idea, but how would this work? Most identification starts with a spore print. What if instead of an AI to identify mushrooms it was software that used a classification system like what is described in "Mushrooms Demystified". Edit: Should clarify most reading I have done on mushroom ID involves taking spore prints as an essential step but it's not always the rule.
- harry8 6y agoIsn't the volume so low on that and the latency requirements so undemanding that ML is overkill to get the answer as well as the accuracy issues with false positive for "not deadly" being somewhat asymmetric? I still think of ML as having a niche of "mostly right is ok" and useful for very, very large volume otherwise one or more people does better for less. That may change in time. Self driving cars are very close now they say, but i suppose we've been hearing that for a few years without getting there.
- raverbashing 6y agoI think this was posted already (a couple of years? ago) Anyway, yeah, it wasn't a good value proposition (and is it just me or GlacierMD is a bad name for this)? Because in the end, it doesn't matter much if you don't get "the absolutely best choice of drug". If it solves your problem great, if not, doctors can exchange it, but that's when the drug or dosage is bad, not "not great".
- jaywalk 6y agoFrom Glacier, it's a very short mental route to Titanic. So, yeah I'd say naming your product that brings up thoughts of the Titanic is not great.
- stevewodil 6y agoI would definitely look at antidepressants on GlacierMD, because I think I want to take one but the options and side effects are all over the place
- yawnxyz 6y agoyeah if it was something like "we can recommend a cheaper drug" then there might be an incentive... but also that's not how drugs are even priced. The healthcare world is such a mess. Charging doctor's offices for SaaS is very very tricky.
- gjs278 6y agoit would probably cost what, $20 a month to keep this on line if it has very few users? why not just keep it online and stop updating it?
- joeraut 6y agoOriginal post from January 2020: https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=21947551
- nickjj 6y agoThat was a fun read. I wish the author mentioned how much he was trying to sell the service for. It could have been $59 a month or $599 a month and with doctors you could potentially expect the same answer. I'm not a psychologist but some of the author's quoted text came off extremely demeaning in written form. If the author happens to read this, did you really say those things directly to them? For example, Susan (psychologist) was quoted as saying: > "Oh sure! I mean, I think in many cases I'll just prescribe what I normally do, since I'm comfortable with it. But you know it's possible that sometimes I'll prescribe something different, based on your metastudies." To which you replied: > "And that isn't worth something? Prescribing better treatments?" Imagine walking into the office of someone who spent the last ~10 years at school and then potentially 20 years practicing their craft as a successful psychologist and then you waltz in and tell them what they prescribe is wrong and your automated treatment plan is better.
- stevewodil 6y agoIt's actually a very good sales question, I don't find it demeaning at all. If you're on a sales call selling a product that increases user retention and someone says "no we don't need that", you would often reply with "So you have perfect user retention then?" to probe them and re-open the conversation. It could come off as standoffish but when used correctly it's very effective because it gets the person on the other end to open up more and you try to get to the bottom of their objections.
- na85 6y ago>If you're on a sales call selling a product that increases user retention and someone says "no we don't need that", you would often reply with "So you have perfect user retention then?" to probe them and re-open the conversation. Assuming that I didn't initiate the call, if I tell some sales punk that I don't need their product and they come back at me with "So you have perfect user retention then?" my answer is going to be "fuck you" followed by ending the call. Arrogance might work in used car sales but it's not a panacea for closing the deal.
- 6y ago
- brd 6y agoAmusingly enough, I've got a document that's essentially a list of ideas where the business model is spurious at best and on that list is a solution almost identical to what was built here. I appreciate that someone took the dive and then shared the process, pain and failure of seeing it through to its conclusion. The only thing missing is the attempt to raise VC money to scale it to some sort of expert system you can sell to enterprise customers.
- worldsayshi 6y agoTurning the product described in the article into an enterprise product sounds like nonsense to me. The product should arrive to the user that benefits the most. Isn't that people in general?
- sneak 6y agoI think that people are probably misleading themselves if they say they want it, but aren't willing to pay for it. People fork over money for IAPs by the millions per minute, because they want the results. I think if it were truly that desirable, people would have been happy to pay for it. I just don't think it provided that much value to the customer.
- notahacker 6y agoMostly they're being polite (and showing they understand perfectly well how they could use it, so no need to explain its purpose any further thanks). They're not really misleading themselves... Ultimately the author's problem is that he was showing Susan a clever project that looked much more attractive than notes she'd usually consult rather than asking her how many times a year she wasn't sure what to prescribe and how difficult it actually was for her to get a sound recommendation from a source she trusted. Even if he was trying to demo a finished product rather than figuring out if it should exist, asking those questions would still have been more likely to put her in the frame of mind where she asks about or spots the really difficult to ascertain info that has professional liability repercussions rather than just liking the UI and being impressed that this programmer is citing the Hamilton Rating Scale for depression)
- gault8121 6y agoThis article's thesis seems to be that medical professionals are not incentized to provide the best interventions, and as a result, wouldn't pay for this service. However, what the author fails to mention is the competitors in this space that are successful, such as Up To Date, which provides really high-quality research trial data: https://www.uptodate.com/home https://www.uptodate.com/home Rather than building a product that informs medical professionals about effective interventions, I wonder if the creator would have had more success if he deeply explored what sources of information these medical professionals pay for now - do they pay for anything at all, such as UpToDate, and don't want to pay this because it's an additional expense? If the creator found which sources people are using, the creator could sell this database as a feature for these partners and widely disseminate this data through partner channels rather than creating a competing source of information. It seems to be a case of this being a good instance of a B2B2C model, where selling this service to other businesses that sell directly to medical professionals could be more viable than trying to sell directly to them. Alternatively, if the creator wanted to sell to patients, rather than medical professionals, the blueprint here is all of the consumer reports companies, such as Wirecutter, which is one of the New York Times's most popular services. Here, again, a "Wirecutter for medical interventions" could be quite successful, and you could sell this service to media companies that provide consumer reports as a service that would bolster these companies. It's bad the creator wasn't able to find traction, as getting more medical data into the hands of consumers could have a huge postive impact over time.
- dr_ 6y agoA hospital system is incentivized in some ways to get people discharged as soon as possible and ideally with a good outcome. A service like UpToDate is one of the tools that may facilitate that by providing valuable clinical pearls to facilitate decision making. So it's not surprising that UpToDate is largely paid for by large institutions and academic medical centers, and not as much by individual medical providers.
- gault8121 6y agoYes, that's an interesting point. It seems like an individual medical provider is incentivized for repeated care where a large facility is incentivized for a fast outcome.
- _0o6v 6y ago> Make something people want That's a charity. > Make something people want __and will pay you for__ That's a business. You learnt the hard way.
- drran 6y ago> Make something people want __and stuff it with ads__ That's a business.
- PeterisP 6y agoIMHO "Make something people want" implies that people will want to pay you for it[1]. If people want it, they'll come asking you to take their money - if their response is "meh, I'd try it for free" then I'd argue it's misleading to tell that they want it, the most you could say is that they are interested. I mean, he demoed this stuff to people and none of them seemed to say "wait, can you give me access to this right now? Pretty please, I'll be your pilot test user, but I want to have this?" - I can't see any evidence that would justify the author claims "Consumers wanted it, doctors wanted it". The doctors called it "What a fun project!", the doctors called it "useful", but none of them wanted it the way they might want a cup of coffee i.e. being willing to give something at all to get the thing they want. [1] the other limitation is whether they can afford to pay you despite wanting it; there are products/markets where the target audience is eager to pay but their collective budget is too small for the scale you need.
- adamlangsner 6y agoHe quotes Strategic Marketing Management, which is a great book if a bit academic. Another great quote I always remember from that book: "Marketing is not about selling a product, but about figuring out what product to sell"
- computerlab 6y agoIf you want to see an index of meta studies, you can check out the Cochrane Collaboration: https://www.cochranelibrary.com/ https://www.cochranelibrary.com/ It’s mentioned in the book Bad Pharma which has a pretty good breakdown of how drug marketing to consumers and medical professionals distorts decision making.
- laser 6y ago“Doppelganger has created value for the customer but not for the company.” Tell that to “Celebs”, which’s sole app function is the described and makes ~$200K MRR.
- twobitshifter 6y agoThat’s shocking to me. They have subscriptions? Why is someone subscribing to an app like this? Looked at things on the App Store. It’s not clear what a subscription gets you but they’re charging $4.99 a week for the premium features.
- rdiddly 6y agoYeah, I was going to chime in and say "I bet Doppelganger would make more money than GlacierMD." Cynical content warning: Precisely because it's not geared toward helping others, which no one gives a shit about, and is all about your photo of yourself which everybody obsesses over.
- mbay 6y agoshould have made it enterprise software for HMOs - they profit when their population has better outcomes. Or sell it Epic or something and they'd package it into their systems.
- eightysixfour 6y agoI remember reading this the last time and it was posted and I still think the core failure is that the author didn't actually recognize the issue he was solving. He thought the problem was choosing the most effective medicine when the real problem was decision fatigue looking at endless shelves of things that all seem to do the same thing. Those two problems sort of look the same, but the latter cannot be resolved by selling the tool to doctors in their offices. The tool should have been designed (IMO) as a consumer tool, either a kiosk at CVS/Walgreens/pharmacies to assist with OTC med selection or possibly as a website with ads/referrals. I would absolutely choose a pharmacy over another as a result of them having something to help through that process, especially when I have a headache.
- ihumanable 6y agoI'm grateful for this comment because it put into words the thing I couldn't. I'm reading the epiphany part of this post, to quote: You have a mind-shattering headache. You're standing in the aisle of your local CVS, massaging your temples while scanning the shelves for something—anything—to make make the pain stop. What do you reach for? Tylenol? Advil? Aleve? Most people, I imagine, grab whatever's cheapest, or closest, or whatever they always use. But if you're scrupulous enough to ask Google for the best painkiller, here's how your friendly neighborhood tech behemoth would answer: [Screenshot of Google Search Results] Oh thanks Google that's just all of them. ---end quote--- The author immediately identifies that this isn't a real problem, by their own admissions that "Most people, I imagine, grab whatever's cheapest, or closest, or whatever they always use." Yea, most people when they have a headache and know that most painkillers on the market will result in about the same degree of relief, don't bother to cross reference a medical meta-analysis, because they have a headache and if the $0.01 worth of aspirin doesn't make it feel better they will just take a second pill and eat the penny. I like the author's conclusion about how to quickly validate business ideas, but even in the title the author still holds firm to the belief that this was a "fantastic startup idea" even though reality seems to think otherwise. Was this such a great idea, do most consumers actually want to review a meta-analysis when picking their OTC medicine, or do most people just try a few things, get influenced by advertising, and purchase the most reasonably priced medicine they think will help. I am just a single data point, but I don't normally feel naked and unscrupulous when I just read the symptoms that a medicine treats and pick one, and that strategy generally works just fine. Solution in search of a problem and also in search of humans that act in this weird atypical fashion.
- hartator 6y ago> So in July 2018, nine months and $40K after starting GlacierMD, I shut it down. [...] The idea is that if you build something truly awesome [...] Where did I go wrong? $40k and 9 months is not that much. Either you gave up just before you figure out how to make the business work or maybe GlacierMD wasn't that revolutionary. Why not open sourcing and publishing all that work? You can still recoup some money via ad money even if it's not the millions you were expecting and at least you have something to show off.
- deleted 6y ago[deleted]
- analyte123 6y agoIt sounds like GlacierMD not only presented results from meta-analyses, they made a platform to make them easier to do and did their own but didn't publish them. If you built a platform to make doing meta-analysis easier, you could collaborate with medical researchers and institutions who are publishing meta-analyses. Maybe give it to them for free at first, maybe get an author credit, some PR, and more sales leads. Researchers can probably use grant money to buy access to your platform and still save money on paying analysts to do things manually.
- LurkerAtTheGate 6y agoPrecisely what I was thinking - a tool to analyze medical studies, compare, and provide easily digestible results is a tool for pharma, not providers.
- jonathan-adly 6y agoHe needed a co-founder who has experience in health care. As a Clinical Pharmacist and a developer - this idea would automate part of my clinical pharmacist job and is viable. He needed to sell to hospitals and PBMs as a tool to automate formulary management. Selling to those entities are really *really* difficult and there is no good distribution channel, but doable with an experienced person who sold them stuff before.
- madamelic 6y agoThe current ideology of needing to go big fast kills a lot of decent ideas. Everyone thinks there are two modes for a service: dead or worth $1B+. Not to like bash you while you are down but you may have been able to do this while working and not spending $40k on contractors. Not everyone needs to raise $10M, get a flashy office, employ 200 people and have all of the trappings of a "successful" startup founder; if anything, that's antithetical to what you should be doing. No MVP, no testing their model, just straight to "Next Best Thing". It definitely hurts, I've been there too for my first "next big thing" and I doubt you'll be the last to get burnt by the image VC firms sell.
- chadash 6y ago$40K is not much to put into a business. You'd likely be putting down more than that just to open a convenience store. Sure you need to spend a lot of money to grow a $1B+ business, but the same is true for a $100M business or a $10M business and even most $1M businesses.
- madamelic 6y ago$40k is a lot to put in a business you have no idea if it can make money or whether it is needed. It's a definite that people have to eat. I would assume most failures in restaurants and convenience stores are operations, not a critically flawed business model. --- But yes, I guess $40k is less than $2M, but it also takes $40k away from another venture and possibly having to go back to a day job to take another run at something. All because you didn't validate the problem before cutting off your income source.
- heavenlyblue 6y agoYou would not need to put up a lot of money if you just came to a market to sell some vegetables. For less central areas you could potentially sell stuff for free. Convenience store is a bad example as these are heavily standardised by now: we all expect a high diversity of products and thus the equipment needed to store it
- abiogenesis 6y ago
- eecks 6y agoWell written - that was an entertaining read.
- jokethrowaway 6y agoThis was a great read! Doctors definitely don't need your product, as they pointed out. But consumers do! I think you should have sold to consumers. Having three doctors in my close family, I often found that whatever the tired doctor at the hospital is recommending is in contrast with what a doctor who care about my health (and is willing to look on their proprietary platforms) is recommending. That's why you ask different private doctors' opinions when things matter. I found myself googling studies on what's the better treatment for $x and I would pay for better-than-a-doctor-advice backed by actual studies. I think the problem, in your situation, is the scale of the operation. If you want to do B2C, you often need investments and you can expect to become profitable in a few years. Either find some funding or fix your cashflow.
- hathawsh 6y agoThat was my reaction too. It seems like GlacierMD might have been successful if it had focused on SEO. Whenever someone types "what is the best headache medicine", GlacierMD should have been at the top of the results. The landing page would show the results of the studies for free, but would also let the user sign up so they can enter allergy and preference info and customize the results to them. Nearby doctors would advertise on the site. So, in essence, before spending any money, I would go out and interview doctors to see if they're willing to pay for a channel of new customers. I would also try to gauge how many customers would be willing to sign up and enter their info so local doctors could advertise to them. And, of course, I would check with a lawyer to ensure I'm not bumping into HIPAA.
- ecmascript 6y agoYeah I agree with your comment. Also, he could host it somewhere cheaper after launch and just keep the site up. Getting high up in the SEO isn't really built over the course of one day. I am sure he could self-host it or rent a cheap server somewhere. AWS is crazy expensive so it seems kind of unnecessary to host it there if you are low on cash. I host a site with 40 TB worth of images and my bill is probably way less than his was.
- gremlinsinc 6y ago
- diebeforei485 6y agoBefore spending all that cash or even incorporating, he should have pitched his idea to VC in the health space.
- fourseventy 6y agoThis is the classic case of building a product that you hope will solve a problem instead of finding a problem first then building a product to solve it. The correct approach would have been to have those conversations with doctors before spending $40k to build the product. I've made this very mistake myself but I was lucky enough to have enough runway to start over and talk to customers first then pivot the product to something that they actually need. I call this the "I have an idea for a startup!" issue. You hear it all the time from family/friends. Where they tell you this great idea for a product they had. This is the wrong approach. What you want to say is something like "There is this really interesting problem that everyone in ecommerce is facing right now"
- ummonk 6y agoUh no. He had a problem - how to choose a medicine - and built a product to solve that problem. The issue was that solving the problem isn't something people wish to pay for, not that the problem doesn't exist.
- dvt 6y ago> Uh no. He had a problem - how to choose a medicine... Did he though? He even mentions that customers generally pick whatever (because they don't really care what's the perfectly optimized headache pill they should take) and doctors thought it was neat, but no one really wanted to pay for it. Their solution (e.g. prescribing what they would typically prescribe) was good enough. It doesn't really sound like there's a problem there.
- dewey 6y agoSolving your own problem and then saying "Oh I found someone interested in my solution" isn't really what they mean by finding customers though.
- woeirua 6y agoI don't think most doctors or customers would even consider this to be a real problem. For some specific, rare conditions sure. But for Tylenol? Come on. No one is going to pay for that.
- jarym 6y agoMaybe its just me but I would have approached drug companies to partner with their marketing teams. THAT would have been something worth paying for TO THEM.
- yaboy 6y agoNever approach marketing teams unless you’re Theranos sized courting Walgreens. Corporate marketers hate risk. It’s a great way to lose your cushy job. What I have seen happen is that they embrace innovation, parade you around their offices and never close on a deal. I saw this happen. The founder of BuyYourFriendADrink was the doyenne of Diageo’s hallways but after burning six months of runway no revenue producing contract was inked. Some corporate politicians simply exist to take meetings.
- ohazi 6y ago> There was this giant thing called healthcare right, and its main purpose is improving health My reaction to this was: laughing: Oh, how adorably naive. followed shortly by: crying: Ugh, we're so fucked.
- thebradbain 6y agoI would have absolutely used this -- as a consumer tool. I _would_ even pay a (small) subscription for the service, as I'm an avid user of WebMD who is more often than not overwhelmed by potential treatments for any given symptom, but I admit that most likely would not scale. I do, however, think it makes much more sense as a consumer tool rather than a doctor tool: if I've already gone through the trouble of making an appointment at a doctor, who I trust, I've either given up on trying to resolve the issue myself and will trust their prescription, or I have no idea how to approach the issue or symptoms I'm feeling as communicated by WebMD. Your value proposition is saving the consumer time and effort of booking an appointment to find out how to best fix a minor-medical issue they (or, say, their child) may have. Is that a sustainable proposition? I don't know, but it makes much more sense to me than as a tool to tell doctors how to do their job "better". I'd imagine if you went the WebMD consumer route, too, once you reach a certain user-size, you'd have no problem partnering with pharmacies (or even pharmaceutical companies) to offer coupons for some OTC medicines in exchange for a referral fee, as is standard in the industry (a. la. GoodRx). Then you're providing value to the consumer in the form of recommending useful medicines, providing the consumer a way to get that medicine for a lower cost, saving them time and money spent at the doctor's office, and providing the pharmacy/pharmaceutical company a new customer.
- newbie578 6y agoReally interesting to read. We can all now be captain Hindsight, but no point in stating the obvious, as long as you and others reading it have learned from the story. Although, I have to mention, reading the article and seeing mentions of MVP and no testing or concrete business plan, I remembered the book "Disciplined Entrepreneurship: 24 Steps to a Successful Startup"[1] and I loved how Bill Aulet in the book mentioned the MVP model and gave his own thought: Instead of everyone rushing MVPs, he recommends to people to rather chase an MVBI, a minimum viable business idea, since as he says, the purpose of a business is to create value and capture it, since you are not running a charity. I must say he convinced me, and changed my line of thinking, it does make sense when you think about it, you cannot build the product for the sake of the product. I also like the quote "Real entrepreneurs fall in love not with their product, but with their business plan." [1] - https://www.goodreads.com/book/show/18652777-disciplined-entrepreneurship https://www.goodreads.com/book/show/18652777-disciplined-ent...
- rossmohax 6y agoAnalysing studies and providing summary on various topics is what examine.com does. I am a happy customer, so there is definitely a way of monetising meta-analysis.
- maxrobot 6y agoI am sure that by mining data from people's phones he could have sold users data to the lowest bidder...
- patel011393 6y agoAs a researcher interested in improving evidence synthesis, I would have loved to use this. Can't this still continue as a volunteer service/non-profit/research project? It reminds me of Examine (https://examine.com/ https://examine.com/) with broader application potential...
- MichaelRazum 6y agoI think the idea is good. Something like AI suggested drugs. But I guess that is hard to do the right way. On the other hand if I really care for the a new drug I take. Just using google scholar and quite often you have some summery studies which compare different meds.
- danhak 6y agoHealthcare is tough. There are few markets with more inertia and misaligned incentives than this. With respect to pitching the product directly to clinicians, OP may have misunderstood his target market or overestimated the value proposition. It seems like a very big request to ask a doctor to deviate from a treatment with which they already have a high level of experience.
- Brian_K_White 6y agoSounds like this might work to offer it to doctors as a white label phone app or pwa, that each customer (doctor or group or clinic or hospital etc) skins and gives to their own customers or sticks on their own website. It has the recommendation engine and the doctors marketing looks and some forms of low-friction way to contact the doctor (generate billable service) from email to video chat. Doctor pays for the startup skinning, any feature changes or updates, and a subscription which pays for ongoing development of the engine and the datasets, maybe some related hosting. Doctor maybe gives the app to tge users free, maybe charges if they think they can pull it off, and generates sales from the in-app "help me" buttons. Could have a few quasi-generic versions geared to different kinds of practises that smaller practices could share.
- baxtr 6y ago> But in fact everyone gave me some version of Susan's answer. "We just can't justify the cost," a pediatrician told me. "I'm not sure it's in the budget," said a primary care physician. "It's awesome," said a hospitalist. "You should try to sell this!" Ugh. In B2B People pay either to reduce costs or drive sales. It’s as easy as that.
- gnicholas 6y agoPreviously discussed: https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=21947551 Weird that the blog post is dated Oct 2020 but was apparently discussed on HN in Jan 2020...
- netsharc 6y agoIIRC blogs with fresher dates are ranked higher, or maybe people just click them more. Just the author practicing low-level SEO spamming, I guess.
- jwogrady 6y agoThe author brilliantly makes the case against single payer healthcare. Bravo. Job well done, sir.
- aetherspawn 6y agoPerhaps this would have been a great business model to start astroturfing big pharma by focusing on SEO, allowing users to upvote meds that worked well for them and letting big pharma pay to bump theirs to the top or highlight it or something like that. Or for a given class of med, charge big pharma or individual chemists a certain amount for referral back links. As a consumer your flow is probably naturally: what type? which brand? where is cheapest in my area? There are plenty of energy comparison companies making money that way. They have a lot less tangible data. I’ll be honest - the tech is so cool you nearly made me want to reach out and buy where you got upto. 'Nearly' is code for, yes I'd be interested, but I don't have enough $$ to make you interested vs the work required to build a profitable model.
- david_allison 6y agoSEO on medical topics without expert backing is a notoriously uphill battle as Google can arbitrarily apply heavy penalties to the search results. > We have very high Page Quality rating standards for YMYL [Your Money or Your Life] pages because low quality YMYL pages could potentially negatively impact a person’s ... health > The Lowest rating must be used for any of the following types of content on pages that could appear to be informational: > * YMYL content that contradicts well-established expert consensus. > There is no evidence that the author has medical expertise. Because this is a YMYL medical article, lacking expertise is a reason for a Low rating Source[0] is 175 pages. Grep for "medical" or "YMYL" for more details. [0]: Google Quality Rater Guidelines https://static.googleusercontent.com/media/guidelines.raterhub.com/en//searchqualityevaluatorguidelines.pdf https://static.googleusercontent.com/media/guidelines.raterh...
- ircoder 6y agoOh man! I'm laughing and crying at the same time. I had a very similar experience in my first "startup". It hurt me so bad, both financially and emotionally, that I could do another "startup" for 7 years. Luckily, the next time I came across Steve Blank and YC Startup School materials and instead of burning all my cash over a two years I managed to FAIL my next three startups withing few weeks with a negligible cost. Those books and articles saves your life and money! This is yet another cautionary tale for founders.
- llaolleh 6y agoI love the author's writing style. I found it kind of funny. But there's a lot he could've done better. My top recommendation would've been to find someone in medicine as a co-founder. This could've helped him find flaws in the economic model faster. I still think his project has amazing potential, except that it's going to have to go through a couple of iterations. For example - what if he somehow integrated this information to make it so that it's easier to connect customers to future doctors and take a affiliate fee? Also imagine if we had a better medical search engine. There's so much information in medicine that is still blocked off to consumers. The author mentions that consumers do not want to go through the details - maybe we can make something that can dumb it down for people and put a directory of doctors who can help explain further?
- capiki 6y agoThe author has a great sense of humor. This was really fun to read:)
- offtop5 6y agoI loved reading this, but it doesn't seem like he thought this through all the way. For one you'd want to figure out how you plan to monetize anything you expect an roi on before you start spending all of your money. Two giving out medical advice feels like a giant cluster of potential headaches, and liability. A doctor who trust your website and then maybe one of her patients has a bad reaction, may have grounds to sue you particularly if you charge a fee to use the product.
- boffinism 6y agoFor an article written in October of last year it sure is funny that there's an HN discussion about it from last January... https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=21947551
- amadeuspagel 6y agoWhy not try to fund it by selling pharmacies, or with some kind of affiliate program?
- loceng 6y ago'"Oh, uh—hmmmm," she said. "I don't know if we can spare the budget here, to be honest. It's very fun...but I'm not sure if our practice can justify this cost."' - Susan (psychiatrist) It just goes to show you how haphazard and lacking of scientific method the psychiatrist field is. '"And that isn't worth something? Prescribing better treatments?" "Hmmmm," she said, picking at her fingernails. "Not directly. Of course I always have the best interests of my patients in mind, but, you know, it's not like they'll pay more if I prescribe Lexapro instead of Zoloft. They won't come back more often or refer more friends. So I'd sorta just be, like, donating this money if I paid you for this thing, right?"' - Susan again This is an absolutely disgusting response to me. They don't care because the costs of shitty treatment - medications that fuck a person up - are externalized, the practitioner/psychiatrist doesn't have to deal with whatever severe "side" effects the medications they'll experiment on a person with.
- ddevault 6y agoThis is a case-study in how capitalism fails. It is not a system that maximizes efficiency. Here we have a product which materially improves peoples lives and health, which fails because no one is incentivized to pay for it. If we had a nationalized system it would be a no-brainer for the government to pick up the bill. Capitalism sucks in general terms, but healthcare and capitalism is an awful, evil combination.
- ska 6y ago> Here we have a product which materially improves peoples lives and health Assumes facts not in evidence, I'm afraid. Seriously, people who have been working on evidence based medicine for decades at this point have been struggling with the fact that what he describes as easy "slurp up a bunch of trials data, do the analysis" is actually pretty hard to get right, for a bunch of reasons.
- ddevault 6y agoMaybe it wouldn't have worked, but saying so much is also an exercise in speculation. It was well-received by doctors and patients, there was interest in exploring it further, and even though it may not have panned out - we will never know for sure, because of broken capitalist incentives.
- ska 6y ago> which materially improves peoples lives and health Agreed, saying this is an exercise in speculation. Apologies I could have been clearer. I'm not saying it was a bad idea or couldn't have worked, just that this had not been demonstrated - and it's a big stretch to assume it would.
- ddevault 6y agoI don't know if it's a stretch, but I agree it's a presumption. It's not material to my point, in any case.
- dvt 6y ago> So I built something people wanted. Consumers wanted it, doctors wanted it, I wanted it. Where did I go wrong? A lot of people in this thread are talking about the woes of ethical doctoring, the problems of healthcare, and so on. The reality here is that no one wanted it -- at least no one that he was selling to. I can relate. I've been there -- building something for months and then hearing crickets. The Y Combinator motto -- "Make something people want" -- is actually pretty tough to get right. In fact, it's the crux of any viable business. The reason why 9/10 businesses fail is largely in part due to the fact that they aren't making something people want. Prospective customer interviews suck (especially for technical folks), but they are integral to building a product people want. Doing them before an MVP is crucial.
- ummonk 6y agoThis seems like it needs to be a nonprofit database - perhaps funded by government grants or industry sponsors - rather than a for-profit growth-oriented startup.
- ibudiallo 6y agoI thought I read this here before: https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=21947551 I still feel the same about it[1]: > Don't shut down the website. Keep it running and make the data available in read only mode and add a donation button (alternative to ads). It should cost $5 a month to host on linode or digitalocean. Don't let the money you spent go down the drain. [1]: https://news.ycombinator.com/item?id=21951604 https://news.ycombinator.com/item?id=21951604
- dkarl 6y agoI'm kind of concerned that people read this as satire but miss the most important part, namely the absence of concern about the safety and validity of the results. You know, the part where he stuck some statistical software in front of a database populated by a "motley crew" of contractors and wanted doctors to use it as a shortcut for making patient care decisions. The part where he implicitly compares the HTML spit out by his system to peer-reviewed work by professional researchers. The part where he is proud of "beating" a "record" for least discriminating meta-analysis. Reading this story and talking about his marketing and product development process feels like watching Lovecraft Country and then then only talking about the time travel physics of it. There's something real and awful here, hopefully presented in a fictionalized or highly exaggerated form. The people in my social circles who mistrust tech and despise startup culture -- this is exactly how they see us.
- fastball 6y agoBut... this is peer-reviewed work by professional researchers[1]. He just tabulated them / made them searchable. [1] Given the reproducibility crisis, I'm not sure we should trust these much either, but that's a discussion for another time.
- jkaplowitz 6y agoIs his meta-analysis or its methodology peer-reviewed work by professional researchers? Has any suitably qualified professional reviewed his output?
- marcinzm 6y agoNo, he did, by his own words, a network meta-analysis[1] on the results which combined the results of many studies into a single table. However this was not a mere tabulation or summary of existing results but a fairly involved statistical aggregation of results. In scientific literature this would merit it's own publication and peer-review. [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386629/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386629/
- dkarl 6y ago
- deleted 6y ago[deleted]
- einpoklum 6y agoA few points come to mind: 1. Good thing he wasted $40k that he actually had rather than $400k he might have borrowed. Of course you could argue that "no risk no reward", but still. 2. The idea itself seems to stem from a weird US-consumer-centric bubble. More specifically * "Pain killers"? Those medications have different active ingredients with different effects, only part of which is some kind of pain (and not a single kind). Some are anti-inflammatory, some are analegsic etc. Those are really different things. * Different people have different reactions to medication, even within the same group of active ingredients. One is better served by choosing medication based on past experience is similar situations. * If it's not clear what you should be taking, you probably want to have a doctor examine the entirety of your symptoms and make recommendations. * If some kind of medication is consistently superior to another for almost all people and scenarios, the superior one will likely drown out the inferior one in terms of availability and public awareness. The popularity of multiple kinds of medication usually (?) indicates they are preferable in different scenarios. 3. When I first saw what the novelty was supposed to be, I was unimpressed. I mean, ok, it's not trivial to do statistical analysis in R - but it seems like anyone with some R and statistics experience can do it. It doesn't seem like there's a lot of secret sauce. There might still be commercial viability here, but it's at best risky. 4. What was the initial business plan? Revenue model? Who was supposed to pay for what? Specifically, suppose one person paid for a recommendation for pain medication. Ok, so they got it - but it's not going to be a secret. It's now public.
- xmly 6y agoSo long...
- deleted 6y ago[deleted]
- pramsey 6y agoIt felt like there was a missing chapter! Consumers don't see the value at all. Doctors see the value, but won't pay for it, because it doesn't change their bottom line. Whose bottom line does this change then? HMOs, insurance companies, organizations that want to improve the health of a population in aggregate. They'd pay money to have healthier people (on average) to provide the service to their docs (who see the value) to use for free. Well, maybe; but I was hoping to see that theory validated in the last turn of the wheel.
- yoz-y 6y agoInsurance companies are the real target here. If they can potentially manage to get doctors to prescribe more efficient medication, then they will end up needing to reimburse less and improve their bottom line.
- nextos 6y agoExactly. Some 23andme clones are aiming at insurance companies and national healthcare systems. I know at least two of them personally, with investments from big pharma. If you convince say, NHS, that this service would make their medical practice more efficient they would totally buy it! For this you'd need to hire MDs and play lots of regulatory tricks. Plus, after that, probably private medical offices would follow the lead. Companies doing genetics-based prediction are trying to fight the same uphill battle, and I think it's one worth fighting. So don't give up!
- yudlejoza 6y agoThe same url was discussed Jan of last year: https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=21947551 Why does the blog-post date say 'October 18, 2020'?
- ic4l 6y agovery odd, here is the original when it was published https://web.archive.org/web/20200103170008/https://tjcx.me/posts/i-wasted-40k-on-a-fantastic-startup-idea/ https://web.archive.org/web/20200103170008/https://tjcx.me/p...
- sumthinprofound 6y agothis lines up with my experience - naproxen sodium is the best otc pain reliever.
- ramraj07 6y agoI have read this before but rereading it realized a more fundamental flaw. The author built an amazing tool that's actually worth a lot of money, but not for patients or doctors! The healthcare data analytics industry would kill for a version of this tool done well. Pharma companies and consultants would pay tens of thousands (if not more) to access a tool like this that's kept up to date. He could have sold the IP and rhe data and the protocols (or get acquired) if he'd networked a bit more in this side. It's probably still not too late!
- Tomminn 6y agoThe product is good. Keep going.
- omarhaneef 6y agoWould it make sense to go to whichever drug company ranked #1 and ask them to sponsor? The key would be to remain true to the message if the #1 changed. In all cases you would put the ranking up before asking for sponsorship.
- simonjhu 6y agoThe author of this one quit too soon or his product, despite his posturing and promoting was poor. 1st off he approached an American Drs practice and they said it doesn’t pay for them to use it. He could have gone on to approach a different country, UK, Australia, Canada to name but a few hell France, Germany - the list of countries with a national Health service with KPIs for exactly this purpose. Moral of this story is if you got a good product don’t quit just because America can’t see the value lol. The irony that the American healthcare system didn't value this overwhelming.
- agrippanux 6y agoDrug companies spend hundreds of millions of dollars showering doctors with incentives to prescribe their drugs. Additionally drug companies run ads where they literally tell potential customers what to "discuss" with their doctor. Honestly I think a day or so of research into how drug companies market their wares would of probably saved this guy $40k. His work is interesting as a free product, maybe as a side project could of grown over time into a potential acquisition. Slapping a paint of React (or Svelte) on top of his Excel-driven POC and a "show Hacker News" post might of been a better way to go. However kudos to him for not only trying to pursue the idea but also for the write up. It's easy for me to armchair quarterback this one, especially since my father was a doctor who got hammered weekly by drug companies, but I'm sure his blood/sweat/tears will pay off in other ways.
- ely-s 6y agoThis quote. > We worked at a startup that leveraged autonomous blockchains to transfer money from naïve investors to slightly less naïve twenty-somethings. There are worse gigs.
- jakubriedl 6y agoI have very similar experience in very different field. About 8 years ago, we've built a SAAS for purchasing material for companies using auctions. The idea was that if it will be super easy for companies to do reverse auctions and use them to buy material they will save a lot of money (proven concept in those who actually used it). But what we learned after some time was it didn't matter. Because people in the companies responsible for buying material didn't really care for how much they buy it. They care that they call their favourite supplier have a nice chat and then order whatever they need. And those suppliers throw some "gifts/rewards" to the package here and there. And without appraisal of those people the business owner never said yes. The thing was that those people who effectively decided if they will use it or not didn't benefited from it at all. We haven't lost so much money on that, but the lesson learned was huge.
- zaczekadam 6y agoMe and my fiends went a very similar path with a different product. We made an Android and iOS app that would help learn programming by wring actual code. Users loved it. They were spending 10 minutes in the app on average! Some spent over 2 hours a day and would finish all the content in two days. Even though, nobody wanted to pay for it. We figured, we would never be able to bootstrap with ads alone so we had to focus on something else.
- LockAndLol 6y agoHealthcare system? More like moneycare system. I like his idea and would've also been naive and idealistic to believe doctors want your best. However, you learn the hard way, even in Europe: doctors want your money. If they get a lot of patients their goal is to minimize time with you. 5 minute consultation, prescribe an antibiotic without ordering a lab test to determine if it's even bacterial, next! If they don't get a lot of patients, then diagnose something that requires multiple treatments or prescribe something that kinda helps but not completely. They'll come back to you sooner than later and TADA you have a "subscriber".
- ffggvv 6y agowonder what wouldve happened if instead of trying to make money he focused on getting venture funding and growing big as a consumer site? seems like alot of companies these days dont have a monetization stategy.
- Haegin 6y agoThis seems like it might be more valuable to a health insurance company or a government health agency than to doctors. Basically the tool tells them what to prescribe to be most effective so customers don't have additional future claims, and this saves the insurance company money. They can also offer it to doctors who have agreements with them as an incentive to sign on etc.
- SMAAART 6y ago> Make something people want. It's Y-Combinator's motto and a maxim of aspiring internet entrepreneurs. The idea is that if you build something truly awesome, you'll figure out a way to make some money off of it. > So I built something people wanted. Consumers wanted it, doctors wanted it, I wanted it. Where did I go wrong? There's a HIUUUGE difference between what people say they'll do and what they will actually do.
- stevenkkim 6y agoYes. There's also a huge difference between what people want and what they are actually willing to pay for. I bet many of the people interviewd by the author would have be happy to use the product on occasion if it had been free.
- hereme888 6y agoWhy not ask funding from the NIH, or sell access to the companies doctors use to get their suggestions, like UpToDate. I can see why doctors themselves wouldn't pay for the service; it's a net loss of money in the business sense, and they already believe they're prescribing evidence-based treatments, maybe just not THE best evidence-based Tx.
- sargun 6y agoI mean, I think that the people to target with this would be insurance companies, public health organizations, or employers. You're generating value for them. Unfortunately, those folks aren't very easy to sell to.
- Throw6away 6y agoYou were lucky. Good on you for getting out when you did!
- braddeicide 6y agoAs a few people have pointed out now, the insurance companies would be the customer. If your software allows patents with disease X to recover 5% faster and they spend a billion on disease X claims each year your software instantly has 50m value to them. You should be able to find a bunch of examples of how much Americans spend on different medications a year, extrapolate the differences in recovery rates from correct and incorrect prescriptions to that value. Additionally, I'm sure they audit Dr prescriptions, if you get the insurance companies to use your service in the audits the hospitals will also purchase it to pre-audit themselves. Perhaps the drug companies can mandate its use. If you can't get a business to want your product, make them need it :)
- crsv 6y agoHe paid $40K for a real life course on how to do market validation that he’ll never forget.
- foolinaround 6y agoloved the self-deprecating humor... loved the style..
- aladoc99 6y agoI have to say, this sounds to me like trying to market an expert system for experienced woodworkers to choose the best chisel for a particular task based on the type of wood, size of the cut, etc. Practitioners have strong opinions regarding the implements they use; they use them in concert with other implements and modalities; and the small differences that may emerge from this kind of analysis are likely to be swallowed up by differences in copay or other things besides pure efficacy.
- danaliv 6y agoI was reading this as a licensed professional in a different field, and trying to imagine someone without my licensure trying to sell me an app that made my decisions for me. Let’s just say this was always going to be a tough sell, no matter how good the economics looked.
- vmurthy 6y agoIt is tough to see one's project(s) fail but in hindsight, I wonder if the author could have gotten feedback from customer even before writing a single line of code to do the meta-analyses (let alone paying contractors). This is on the lines of "simple but not easy" but here goes anyway: 1. Identifying "who am I solving this for" 2. Identifying "who might pay for this" 3. Prototypes , mockups of the solution 4. Getting out of the building (GOOB) and talking to the end customers (the ones who will pay) and validating 1 & 2 before going full steam ahead
- EugeneOZ 6y agoYou need to write books, really.
- deleted 6y ago[deleted]
- dlowe24 6y agoA tale that is foundational and reoccurring.
- vmception 6y agoDoes Wharton’s book really say that? If you just make value for the company it is a scam? If you call it entertainment purposes I guess its fine
- bestnameever 6y agoI think he could had licensed this tool to another site. Maybe even webmd would want it.
- andi999 6y agoThe graph about the curves (escitaloprame, sertraline) seems like a joke. The curves bending upwards indicating that everybody will be worse? Looking at the raw data (points in the graph), there is really no indication for that and if I were to see that I'd prefer the raw data.
- ck2 6y agoTo me at least that was an impressive amount of working your butt off for something you believed in.
- peterthehacker 6y ago> We worked at a startup that leveraged autonomous blockchains to transfer money from naïve investors to slightly less naïve twenty-somethings. What does it mean to “leverage autonomous blockchains”?
- sova 6y agoMore and more developers these days give their work away for free and create a Patreon. I don't know if it would work in this case, but if enough people got wind of the idea, perhaps it would at least equalize. Not all brilliant ideas are meant to be businesses, so why not give users the options to support something they find useful? You can easily thermometer the demand this way, and if there's a [community] need that you are fulfilling, supporters will show up. You can always hide more advanced features behind the Patreon subscription levels, too. It sounds like what you are really after is a community that vets health knowledge, and this could be one cornerstone of that.
- ridaj 6y agoSounds like $40k spent to learn a lot of the useful stuff you'd learn in a basic MBA program. Probably a better deal than the MBA :-)
- bastawhiz 6y agoI can't see this being useful for consumers directly. I'm not going to pay to optimize the efficacy of the pills I get for a headache or heartburn or bloating or whatever. If I choose one brand/compound over another and it's 20% better...what's that worth? $5/year? Maybe? I can see this being useful for problems that are not trivial. Heart medication. Cancer drugs. HIV medication. The sort of stuff where a 20% difference in efficacy is not the difference between me having an extra cup of coffee or not—it's the difference between an extra year on medication and worse side effects or not (or even life and death). But even then, you're not selling to patients—it seems super unethical (or at least immoral) to profit from folks with serious illness who want to know what's best going to keep them from dying. You sell this to the healthcare industry. But like the post says, doctors don't...really care. Not that they shouldn't care, but they don't benefit personally, and the patients aren't going to pay them more for it, and the industry will (slowly) get better on its own in the long term. That doesn't feel great. So to me, it seems almost obvious that the customer here is the pharmaceutical companies. They've got money to burn. They pay HUGE amounts of money for display ads and instagram stories which literally don't even tell you what the damn drug does. During Ru Paul's Drag Race this past week there was an ad for a medication which didn't mention what it treats or who could take it. Make the data free to consumers and doctors. Hire someone to call every cardiologist and HIV specialist and oncologist and whoever else in eastern standard time. "Hey, I've got this thing that will tell you what's likely the best drug for patients. It's free to use, and we'll send you a free mug after you use it 100 times." Then you call up every pharmaceutical company you can find and say "Hey friends. We'll put up a profile page for each of your drugs and make sure they're represented with independently verified data. We've called X thousand doctors who will be using this. Pay us $Xk/year and we'll make this happen." You could probably do the same thing for healthcare companies (e.g., Kaiser): "pay for a license for all of your doctors and you'll have better health outcomes for your patients." This is obviously untested, but if you exclude the doctors and the patients as potential customers, you're left with a pile of companies with a lot of money. I would love to hear from OP why this wasn't something they pursued.
- Luvnit 6y agoYou say “ So I built something people wanted. Consumers wanted it, doctors wanted it, I wanted it. Where did I go wrong?” The fact that the people giving you the money I.e doctors / hospitals didn’t want to pay for your product proves you built something no one wanted. Wanted enough that they were willing to pay you money for it. Or go out of the way to find the budget for it.
- iandanforth 6y agoOr the incentive systems in the US are completely screwed up when it comes to healthcare.
- dehrmann 6y agoI was going to point out Kaiser, an HMO that provides both insurance and services. It's reputation is mixed. HMOs like that, or maybe the VA, would be perfect customers because their interests are mode aligned. Private practice doctors, not so much.
- Aperocky 6y agoNah, everyone wanted it, but for free. I think the only thing that went wrong is the budgeting, OP might have made it had he dumbed it down a little and made it 100x more simple (on the backend).
- saran2win 6y agoThis sounds like a classic Solution In Search of Problem (SISP)". I think the author has a great idea but it just took so much effort to find the problem. When nobody jumps out of the chair and starts writing a check, then it is time to start iterating the MVP or pivot. I'm pretty sure there's a problem in the world that needs this solution, but it just take inundated effort to find product market fit. Instead, when you start with the problem it is somewhat easier to get to the point of the product market fit.
- danieldbird 6y agoGreat and funny read.
- gavanwilhite 6y agoSeems like maybe you would have been good to talk to Kaiser or other companies more directly incentivized towards positive health outcomes?
- deleted 6y ago[deleted]
- steve_taylor 6y ago> It had been a bit of a working assumption of mine over the past few weeks that if you could improve the health of the patients then, you know, the doctors or the hospitals or whatever would pay for that. There was this giant thing called healthcare right, and its main purpose is improving health—trillions of dollars are spent trying to do this. So if I built a thing that improves health someone should pay me, right? > I said goodbye to Susan and tried to cheer myself up. I had ten more meetings with doctors all over the Bay Area—surely not all of them were ruthless capitalists like Susan. Maybe they would see the the towering genius of GlacierMD and shell out some cash. This is pretty accurate, unfortunately.
- dboreham 6y agoShould probably give people like this a lollipop too.
- t_swapnil 6y agoJust an interesting thought, wouldn't the medicine companies be the better place to market this product? This fits the marketing principle of 'benefit to all' the author has highlighted. They could have probably used it to analyze how their product fares against their competitors.
- eterevsky 6y agoAs a user, I'd definitely pay a moderate subscription for this service. I think it's super useful.
- ano88888 6y agoThe author can write a story than a lot of writers.
- tptacek 6y agoIt's been mentioned a couple times on the thread but I'll third it: this post succinctly captures the problem statement of _The Mom Test_, which is a short book about how to structure your product/market fit work to cut the crap and lock in on a product that people will actually pay money for. It's good, more people should read it.
- ronyfadel 6y agoSeconded. Do not start a company before running it through the Mom Test.
- a-dub 6y ago> "Hmmmm," she said, picking at her fingernails. "Not directly. Of course I always have the best interests of my patients in mind, but, you know, it's not like they'll pay more if I prescribe Lexapro instead of Zoloft. They won't come back more often or refer more friends. So I'd sorta just be, like, donating this money if I paid you for this thing, right?" this is the problem. the incentives in healthcare are messed up. doctors are paid for their time, not for their outcomes. if a patient comes in and is prescribed a therapy, and they don't have to come back, the doctor should receive more than if the patient returns because the therapy had an issue.
- vasco 6y agoMaybe we should also pay programmers based on outcome then, and you get less if your % of bugs is higher than the team average, sounds like a great idea, eh? Maybe a day without pay if you bring down the live service? I'm pretty sure this wouldn't work. The first place to put it in place, be it a hospital or a tech company, would just have most people quit. Sometimes things are hard and people need to know the business has got their backs as long as they try their best. Reducing pay on bad outcomes is institutional blame culture on overdrive.
- inopinatus 6y agoIf you paid doctors by individual outcome then the incentives would be even more messed up, since no-one would want the tough or ambiguous cases. This is opposite of the desired outcome, which is that the best doctors see the hardest cases. Always pay professionals for their time. Patients are not widgets.
- GordonS 6y agoI was horrified when I read that line too. I have this crazy idea that most doctors go into the medical profession because they want to help people - her attitude is awful, IMO.
- thehappypm 6y agoBetween the lines, the real doctor perspective here is "Medicine A, which I have been seeing success with for decades, is (according to this site) less effective than Medicine B. I really trust Medicine A, so I don't think this is enough of a nudge to make me change my mind necessarily."
- kangaroozach 6y agoResonates with me big time. I also bootstrapped a digital health startup called AnywhereMD with a team of physicians. At first it was a triage app that evolved into a messaging platform. The triage had a similar value proposition; get people to the optimal point of care and they will avoid unnecessary and costly ER visits. Self insured employers and accountable care organizations would reap the savings and therefore pay per employee or insured per month and drive people to use AnywhereMD before deciding where to seek care. We were bootstrapped and had a hard time convincing large companies that we were legitimate since we were so small. The biggest parallel I can see is that in healthcare, cost savings and better outcomes are obscured, hard to see, delayed etc.... So it’s not easy to prove value and then capture some of the value for your self.
- yholio 6y agoSo I built something people wanted. Consumers wanted it, doctors wanted it, I wanted it. Where did I go wrong? I think it all went downhill where he refused to setup a fake business model with fake revenues and customers, pour anther 10K in online astroturfing touting the marvelous startup clearly heading for unicornicity, then immediately hit all venture capitalists and investment funds with financing requests. This is a big, once in a life time, fake medical company idea, he could have easily gathered capital in the 9 figure range before retreating away on a tropical island to seastead.
- bencollier49 6y agoDoesn't this count as "practising medicine without a license?"
- paul7986 6y agoMy startup journeys were not successful in the eyes of the world in terms making money or blowing up. Yet the experiences, people I met and most importantly the skilled (developer/designer as a living) I learned made it successful for me! It was the best way to learn how to code for me personally.
- caffeine 6y agoHe missed the obvious point: sell it to the pharma companies as a platform to promote their products. Guy could've been a zillionaire by now.
- jitix 6y agoI think it's a great idea but looking at the product I'd say that the value proposition isn't enough for anyone to buy a subscription. Maybe an ad supported website (like WebMD) that licensed professionals could check to validate their own assertions. Also "$0.50/year per user" is actually a great amount if the site was made for a global audience. And as an AWS cloud engineer I'm actually curious at the AWS cost breakdown. If done properly this kind of data processing and site hosting costs would be trivial.
- jeanlucas 6y agoYeah, this is the kind of project that could fly really well as an "indie hacker" style. Just one person running it all. Today's cloud tools allow that. edit: but I don't think that's what the author wanted. Not really sure what they wanted, to have full success by month #8? Drop it all for an idea not even tested yet sounds very very amateur.
- deleted 6y ago[deleted]
- deleted 6y ago[deleted]
- coldtea 6y ago>Make something people want. It's Y-Combinator's motto and a maxim of aspiring internet entrepreneurs. The idea is that if you build something truly awesome, you'll figure out a way to make some money off of it. So I built something people wanted. Consumers wanted it, doctors wanted it, I wanted it. Where did I go wrong? I'm not sure he still gets it. He didn't built something people want (even less so want enough to pay for). He built something he merely thought people should want. In the end, people didn't really want it.
- breakyerself 6y agoIf it had succeeded and was ad based I'm certain I would have used it occasionally assuming I knew about it.
- username90 6y agoSome would like it, however the problem is that you wouldn't use it enough for it to be worth it to him to build it. Quote: > Turns out the world's biggest health website makes about $0.50/year per user. That is...not enough money to bootstrap GlacierMD.
- splendidHaiku 6y agoDoes not always work like that. Did people „want“ cars when there were only horses. Or Facebook when there was just email. Sometimes you build something and only after people realise that they want built thing.
- coldtea 6y ago>Did people „want“ cars when there were only horses. That's not the right question (as based on the well-known quote). The right question is: if I showed people a car on actual paved roads, with its load capacity and speed benefits over horses, would they jump for it? And they did. But for this thing, they didn't. This person didn't merely talk about his yet un-made app to some people who couldn't even imagine what could be. He showcased it, working in full form, and different target audiences could not care less.
- henearkr 6y agoLike other comments I think the author addressed the wrong market. Essentially he developped a tool to facilitate meta-analyses, both building them and then presenting the results. So, his customers should have been people who usually are investing in meta-analyses. Doctors are not investing, merely passive consumers of existing analyses they can find. So, research teams should have been his target, probably mainly in academia and in public health bodies. He could have grasped public funds. The right market was researchers, i.e. in real life usually the ones owning biology PhDs (and often professor chairs), and not the physicians with medicine PhDs, who are the engineers of the human body (engineers applying known solutions, versus researchers looking for extending or consolidating the knowledge).
- artembugara 6y agoIn a nutshell, this is just another story of coding something cool. Just to realize that no one will pay for it 8 months after. YC also says all the way through "Talk to your users/prospects". That's how you "Make something people want".
- howlgarnish 6y ago"Of course I always have the best interests of my patients in mind, but, you know, it's not like they'll pay more if I prescribe Lexapro instead of Zoloft. They won't come back more often or refer more friends. So I'd sorta just be, like, donating this money if I paid you for this thing, right?" But you know who would pay more if they prescribe Lexapro? The manufacturer of Lexapro, and that's who he should have pitched this to. And they have the marketing muscle needed to make it scale. That said, there's all sorts of conflict of interest/slippery slope issues going down that path, and I'm not sure they would buy this either, but they'd still have been his best bet.
- Stammon 6y agoHave you contacted any doctors or hospitals in Europe? We do take healthcare more seriously here, so I'm wondering whether you get the same response.
- ThePhysicist 6y agoIMHO most articles about medical conditions should be banned or severely downranked by Google, as they create far more problems than they solve. Over the years I've freaked out several times because I googled some symptoms I had and of course was presented with a slew of SEO-optimized articles that associate them with serious diseases. The thing is, those articles are mostly written by marketing folks that rephrase stuff from Wikipedia or medical literature, but without knowing anything about the conditions they write about. The sole purpose of these articles is to increase the page rank of a website and generate page views that can be monetized. Of course it's like that with almost every topic on the Internet, it's still highly unethical though as it incites unwarranted, existential fears in people. Presenting medical trials and statistics to an uninitiated reader will probably also cause more harm than benefit, so it's good he canned this idea.
- fasteo 6y agoNot directly. Of course I always have the best interests of my patients in mind, but, you know, it's not like they'll pay more if I prescribe Lexapro instead of Zoloft. They won't come back more often or refer more friends. So I'd sorta just be, like, donating this money if I paid you for this thing, right? Coming from a Doctor, this is extremely worrisome and borderline inmoral
- wesleywt 6y ago40K is pretty cheap for an education these days. Especially a really top notch education of the real world, which this guy got.
- aj7 6y agoSee that sertraline vs. Lexapro curve? Pretty similar. Pharma is very competitive. Successful pharma products are so close doctors use intuition, experience, and hunches to break ties. Also, they’ve been shown detailed one-of curves by pharma salesladies, EACH of which purports to show that THEIR drug is superior. Then there’s that $0.50 revenue/user problem.
- john_minsk 6y agoI didn't get it. He starts as if this is b2c kind of business, but then shows screenshots with service aimed at drug researchers. If it is b2c: make an app for the phone. Screen1: human body, where you can choose places where you feel unrest. Screen2: describe what is wrong Screen3: "based on your answers and your geolocation you can get these 3 remedies which are safe" or if something extreme is going on "please see the doctor, in the mean time you can use aspirin to relieve your pain" *I usually call mom when I have headache, temperature or diarrhea cause I constantly forget which one should I take. I'm 30:-( I would use such app for these hints. For anything more serious I would go to doctor and wouldn't self medicate. Monetization(Hard): Subscription for extra features like tracking of drug dosages and keeping track of your home stock. Would probably be beneficial to someone who takes a lot of drugs all the time. Monetization2(Medium hard): deals with local pharmacies to be able to provide recommendations where to buy a specific drug advised by the app. Based on screenshots what he built is b2b app for doctors?
- john_minsk 6y agoone more thing 5 minutes later: I was travelling a lot past 4 years and would be great: Buy international insurance within an app and have a list of local hospitals I can go to Be able to "download" integration with local pharmacies like it was with maps.me These can be sold. If I'm in India and got Delhi Belly I would pay 2-5 USD to find nearest pharmacy/hospital or order drugs to my hotel
- thepolymath 6y agoThe monetization part of the idea is as important as the idea. A lot of first time entrepreneurs waste time on a project that is impossible to monetize.
- ozim 6y agoThere is so much to take out from this story for developers who want to do the same. Marketing is hard, making people pay for something is even harder. Your idea about "fantastic app" might not be so fantastic for target group. Problem is there is so much more to any business that we don't know from the outside. There are things that unless you are in the group you are not able to notice because those are "dirty" trade secrets.
- dustinmoris 6y ago>I had literally nothing to say to that. It had been a bit of a working assumption of mine over the past few weeks that if you could improve the health of the patients then, you know, the doctors or the hospitals or whatever would pay for that. There was this giant thing called healthcare right, and its main purpose is improving health—trillions of dollars are spent trying to do this. So if I built a thing that improves health someone should pay me, right? I think the author makes the wrong assumption that his product does improve health and that the current practices of GPs or other health professionals don't (as much as they could). He misses the most important thing of any professional and successful health care worker: experience. If a doctor has a high success rate with drug A on their patients then even if some website tells them that drug B _could_ be slightly better why would they try it? There has to be more of an incentive than _just a website saying so_. The doctor has a high success rate with drug A, has seen it working many times and knows everything about side effects or maybe the lack of those. If nobody has complained and it works miracles then it would be foolish for the doctor to start prescribing a new drug simply based on a random website's recommendation. Also doctors do have to stay current and they get medical journals sent home, attend training courses and conferences and learn about new stuff when it's actually relevant and needed.
- ChrisMarshallNY 6y agoI enjoyed that read. Sounds like it may be a familiar refrain in the Startuposphere.
- btomtom5 6y agoFunnily enough, the best apps that that use ai to find your celebrity look alike are making hundreds of thousands per month in subscriptions and ad revenue
- cryptica 6y agoI can fully relate to this experience. I think it's no coincidence that the businesses which are the most useful for society are the poorest. Their target customers have no money. Value producers tend to be honest people. They believe that they have to work to get money. That's why they can't get any. Those who have direct access to the money printers know this better than anyone. You need to be a fraudster to make money in this economy. I learned this the hard way working in open source. Now I work in finance. If you can't beat them, join them... Help accelerate the financial collapse. Education, medicine, software which lets people work more efficiently and save time; they're a waste of time financially. The fiat monetary system wants more bureaucracy, more jobs, more surveillance, more manipulation, less efficiency, less free time for everyone. Most people who made money in this scam system are fraudsters, attention hoarders, legitimised money launderers, risk externalizers...
- tony0x02 6y agoThere is a book titled Powerful Medicines that proposes including efficacy as a factor in new drug approval.
- 02020202 6y agoi wasted 10 years...i'd take the 40k over 10y any time.
- simonebrunozzi 6y ago> We worked at a startup that leveraged autonomous blockchains to transfer money from naïve investors to slightly less naïve twenty-somethings. There are worse gigs. At least he's being honest about it.
- AzzieElbab 6y agoHey MS, Google, Amazon, Oracle, and countless others invested billions into health-it and made no observable impact. 40k for one of the most popular pharmaceutical site really is a wonder to behold, sorry about the 40k
- ayewo 6y agoI'm guessing that several of these attempts do not properly account for the negative externalities that are peculiar to the health industry. Apple is taking a much much different approach in how they hope to gain a foothold in the health industry, starting with HealthKit and slowly chipping away at the problem with the Apple Watch getting FDA and related certifications. Tim Cook is on record saying that if Apple is to be remembered for something with a lasting impact, it would be in health [0]. Unlike their peers, Apple's strategy in health is anchored on a very very long-term horizon. Would be interesting to see how their strategy unfolds. Fingers crossed. 0: https://www.cnbc.com/2019/01/08/tim-cook-teases-new-apple-services-tied-to-health-care.html https://www.cnbc.com/2019/01/08/tim-cook-teases-new-apple-se...
- chrismatei 6y agoWhy dont you create a platform to save such as data sets. etc. and sell that. I think you were selling the wrong product of your startup.
- nosferatu79 6y agoWhat about selling it to government which provides healthcare to maintain it and make it free for their healthcare system?
- igammarays 6y agoFantastic idea? This is AI snake-oil. If this guy literally thought he could build an auto-meta-analyses that could magically prescribe the right OTC to fix your pain based on a few button clicks, he's trying to play God.
- aejnsn 6y agoIt’s another one of the AI use cases where the problem is built around a solution.
- thefrog 6y agoThe idea was not "fantastic" if there's no market for it willing to pay.
- d0liver 6y agoHow did you write 200k lines of code in nine months? Was that all functioning code? Was some stuff generated? Retaining ~730 LoC per day including weekends for nine months is a really crazy pace and I'd love to hear more about that workflow.
- acvny 6y agoYes, I read this article several years ago. Why is it reposted with a recent date? Anyway, besides all the BS the author wrote, I didn't see the business model. What was the basic - dumb business model? So you find which is the best painkiller. So what? How do you charge users for this? This is one-time info. Once we all agree which is the best, why would anyone pay you for this? And why the fuck did you draw diagrams on your parents' windows? Have you watched the facebook movie too many times?
- acvny 6y agoAnd why did you quit your job? Always validate the idea first and validate it only by making lots of people pay you for it. Not by asking your current boss.
- gremlinsinc 6y agoSeems to me the product here is the database. Doctors don't want another product to learn add to their already saturated load. Most doctors and dentists I know are very non-technical actually. I know a dentist who could barely work email. However there's some software they probably use quite a bit, if those vendors were to license the data, and maybe the graphs generated by the data - THAT is the business model that would work imho.
- jjk166 6y agoInstead of marketing this as a tool to better select drugs, I would market this as a tool to better justify drug selections. When I go to the doctor part of me is always skeptical - are they prescribing this because it is actually best for me, or did they just prescribe me the default and don't care if I have to schedule another appointment in 2 weeks to get a different prescription? Between insurance politics and the difficulties of keeping up with research, there are a lot of perverse incentives out there. I'm certainly not alone in this. Even if I knew for certain the Doctor's interests aligned perfectly with my own, the fact is I am a non-expert and putting my faith in something I am unfamiliar with and don't fully understand is scary. Now imagine if a doctor could instantly put my fears to rest. When I start asking questions, he can instantly put a nice looking piece of paper in my hand telling me why his decision is the best option for me, personally. Maybe I don't totally get what all the numbers mean, but I see my readings, my symptoms, there's a graph on it and the drug prescribed to me has the biggest bar. If that were an option, I'd never use a doctor who didn't do that. Even if it didn't lead to more patient referrals, certainly it would save doctors time answering all the "but WebMD says..." questions, and a doctor's time is worth a lot.
- VEEG889 6y agoI would like to thank WORLDHERBSCLINIC for reversing my father's Chronic obstructive pulmonary disease (COPD). My father was deteriorating on his COPD for Eleven years before he started on WORLDHERBSCLINIC herbal medicine treatment. He was on it for just THREE months,and we never thought my father will recover so soon. Has gained three kilos and can sleep all night without experiencing shortness of breath. I'm very happy to tell the world about this great COPD herbal medicine. Please if you are a COPD patient don't hesitate to visit www worldherbsclinic com for good healthcare and medication. Remember nothing is impossible.